Improving the lives of dependent people and their caregivers!
June 7th 2024
The acquisition of Scemed, one of the leading French manufacturers and distributors of medical transfer and hygiene equipment, represents the third significant external growth operation undertaken by Winncare since Siparex ETI became the majority shareholder in 2021.
The Winncare Group, chaired by Laurent Faugère, is one of Europe’s leaders in the manufacture of medical equipment designed to improve the lives of people with reduced mobility and those who care for them (caregivers and healthcare providers). The Group operates in two strategic markets (home care and nursing homes) and offers a comprehensive range of products (therapeutic mattresses and cushions to prevent pressure sores, connected devices and lifting cushions to manage falls, medical beds, transfer systems, etc.) and services. This broad portfolio has been strengthened in recent years through both organic growth and acquisitions. With five commercial subsidiaries in France, Spain, Denmark, Poland, and the United Kingdom, as well as nine production units (France, United Kingdom, Spain, Poland, and Tunisia), Winncare now positions itself as the European leader in its sector. The Group has doubled in size since Siparex ETI became a shareholder, with a turnover of around €150 million and nearly 800 employees.
Scemed, founded in 1994 by the Folliot family and based in Halluin (59), is a French company specializing in the manufacture and distribution of medical equipment for healthcare facilities (hospitals, clinics, nursing homes, maternity wards). Its activity includes two main areas: transfer (ceiling hoists, stand-up aids, etc.) and hygiene (therapeutic bathtubs, shower chairs, and trolleys, etc.). Through innovative solutions, Scemed enhances patient well-being and improves working conditions for healthcare staff. Scemed generates over €15 million in revenue in a rapidly growing market.
Following the acquisitions of Pharmaouest and Herida Medical in the United Kingdom, this would be the third significant external growth operation for the Winncare Group since Siparex ETI became the majority shareholder in 2021. This merger would offer multiple synergies to the new entity and would notably allow Winncare to strengthen its Transfer offer.
Laurent Faugère, President of Winncare, said, “We are delighted to welcome Scemed into the Winncare Group. We share a long common history, with Scemed distributing our transfer systems, such as the Luna, for over 20 years. Our missions are closely aligned, focused on the constant improvement of the quality of life for patients and caregivers through innovative medical devices. This acquisition would strongly consolidate Winncare’s leadership in the rapidly evolving nursing home segment.”
Nicolas Folliot, President of Scemed, stated, “I am thrilled that the Scemed journey can continue within the Winncare Group, a solid partner with whom we have built long-standing ties. I am convinced that this is a fantastic opportunity for all the teams at Scemed and SC Productions to ensure long-term growth and create success conditions for the company. I wish all the teams much success and will follow the Group’s development with attention and interest.”
Alexandre Tremblin and Guillaume Rebaudet, Managing Directors of Siparex ETI, commented, “We are delighted with the acquisition of Scemed, which would consolidate Winncare’s offer in response to the growing need for patient and caregiver support. This operation would mark a new development stage for Winncare in a market based on solid growth fundamentals. We continue to be proactive in M&A activities with the goal of reinforcing Winncare’s position among the European leaders in products and services for dependency care.
Designed 
Strong brands 
A comprehensive, 
A certified 
Global 
